Atlas Trials

Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Crow's Feet Lines and Frown Lines

Clinical trial NCT01189760 · COMPLETED

Trial details

NCT number
NCT01189760
Sponsor
Allergan
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Facial RhytidesCrow's Feet LinesGlabellar Lines
Start date
2010-09-01
Primary completion
2011-03-01
Enrollment
917

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.